Euro-Med Laboratories Phil Balance Sheet Health
Financial Health criteria checks 2/6
Euro-Med Laboratories Phil has a total shareholder equity of ₱5.8B and total debt of ₱3.9B, which brings its debt-to-equity ratio to 66.6%. Its total assets and total liabilities are ₱10.8B and ₱4.9B respectively. Euro-Med Laboratories Phil's EBIT is ₱652.6M making its interest coverage ratio 2.4. It has cash and short-term investments of ₱1.1B.
Key information
66.6%
Debt to equity ratio
₱3.89b
Debt
Interest coverage ratio | 2.4x |
Cash | ₱1.08b |
Equity | ₱5.85b |
Total liabilities | ₱4.92b |
Total assets | ₱10.76b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: EURO's short term assets (₱5.1B) exceed its short term liabilities (₱3.9B).
Long Term Liabilities: EURO's short term assets (₱5.1B) exceed its long term liabilities (₱1.0B).
Debt to Equity History and Analysis
Debt Level: EURO's net debt to equity ratio (48%) is considered high.
Reducing Debt: EURO's debt to equity ratio has increased from 66.1% to 66.6% over the past 5 years.
Debt Coverage: EURO's debt is not well covered by operating cash flow (9.1%).
Interest Coverage: EURO's interest payments on its debt are not well covered by EBIT (2.4x coverage).